Difference between revisions of "POEMS syndrome"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "[[Trimethoprim/Sulfamethoxazole" to "[[Trimethoprim-Sulfamethoxazole")
Tags: mobile edit mobile web edit
Line 41: Line 41:
 
*[[Aspirin]] 100 mg PO once per day
 
*[[Aspirin]] 100 mg PO once per day
 
**[[:Category:Low_molecular_weight_heparins|LMWH]] in "intolerant" patients
 
**[[:Category:Low_molecular_weight_heparins|LMWH]] in "intolerant" patients
*[[Trimethoprim/Sulfamethoxazole_(Bactrim_DS)|Cotrimoxazole]] 800 mg PO twice per day two days per week
+
*[[Trimethoprim-Sulfamethoxazole_(Bactrim_DS)|Cotrimoxazole]] 800 mg PO twice per day two days per week
  
 
'''28-day cycle for at least 6 cycles'''
 
'''28-day cycle for at least 6 cycles'''

Revision as of 19:35, 23 November 2019

Section editor
Headshot Cowan.jpg
Andrew J. Cowan, MD
University of Washington
Seattle, WA

Social-twitter-icon.pngandrewcowanmd
LinkedIn

POEMS: Peripheral neuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder, and Skin changes

1 regimens on this page
1 variants on this page


Guidelines

EMN

All lines of therapy

Rd

back to top

Rd: Revlimid (Lenalidomide) & low-dose dexamethasone

Regimen

Study Evidence
Nozza et al. 2017 Phase II, <20 pts

Chemotherapy

Supportive medications

28-day cycle for at least 6 cycles

References

  1. Nozza A, Terenghi F, Gallia F, Adami F, Briani C, Merlini G, Giordano L, Santoro A, Nobile-Orazio E. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial. Br J Haematol. 2017 Dec;179(5):748-755. Epub 2017 Oct 19. link to original article contains verified protocol PubMed